IMM
Click for more information
23.0% 33.5¢ immutep limited

success for avastin in europe, page-26

  1. nuts
    701 Posts.
    clock Created with Sketch.
    05/12/12
    16:39
    Post #: 11151105
    My previous reply was to Ymav. FYI. Missed Andrew's post.

    Completely agree Andrew. Though I expect it possible in CVac's case, the FDA would approve based on PFS alone (fast track), as there is little risk to the patient.
    Avastin's approval for breast cancer was revoked primarily because the risks outweighed the benefit.
    This is where I went off-track with my incredulity in my above post - EMA vs FDA.
    PRR Price at posting: 9.3¢ Sentiment: LT Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
SFX Sheffield Resources achieves milestone production, shipments at Thunderbird, WA
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
33.5¢ 		Change
-0.100(23.0%) 		Mkt cap ! $486.6M
Open High Low Value Volume
39.0¢ 40.0¢ 23.0¢ $16.23M 50.19M

Buyers (Bids)

No. Vol. Price($)
4 704297 33.0¢
 

Sellers (Offers)

Price($) Vol. No.
33.5¢ 102135 2
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.